Feb 20 (Reuters) - Cyclopharm Ltd (CYC) :
- RESOLVED TO PAY FINAL UNFRANKED DIVIDEND OF 0.5 AU CENTS PER SHARE
- FY PRELIMINARY REVENUES FROM ORDINARY ACTIVITIES UP 31.1% TO A$23.2 MILLION
- REMAINS CONFIDENT THAT EXPECTATIONS OF TRIAL RESULTS BEING PUBLISHED IN FIRST HALF OF 2023 WILL BE MET
- FY LOSS FOR THE YEAR A$6.6 MILLION VERSUS LOSS A$5.0 MILLION
- CONTINUES TO PROGRESS TOWARD ATTAINING USFDA APPROVAL TO COMMENCE COMMERCIAL SALES OF TECHNEGAS IN US MARKET IN 2023
- POISED TO ENTER ITS NEXT GROWTH PHASE IN 2023
Feb 20 (Reuters) - Cyclopharm Ltd (CYC) : RESOLVED TO PAY FINAL...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
81.0¢ |
Change
-0.030(3.57%) |
Mkt cap ! $90.02M | |||
| Open | High | Low | Value | Volume |
| 84.0¢ | 84.0¢ | 77.5¢ | $113.7K | 140.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 571 | 80.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 81.0¢ | 1223 | 2 |
View Market Depth
| Last trade - 13.31pm 11/09/2025 (20 minute delay) ? |
| CYC (ASX) Chart |